文献速递分子诊断临床微生物

当医学经济先于医学科学:新生儿HSV分子诊断的挑战

The Tail Wagging the Dog (or the Challenges Faced When the Financing of Medicine Gets Ahead of the Science of Medicine).
PubMed 文献 · J Clin Microbiol · 2018-09-25

该文评论Dominguez等对7例新生儿HSV病患者皮肤黏膜样本的PCR与病毒培养检测性能比较,认为分子检测替代培养多因经济因素先行,小样本支持该选择但需更大研究明确PCR性能,假阳性可致婴儿数月不必要管理。

要点

  • 7例新生儿HSV病皮肤黏膜样本中PCR检测HSV DNA与病毒培养的比较支持分子检测。
  • 许多实验室已因人力成本转向分子诊断,该研究为已做出的经济驱动决策提供依据。
  • 假阳性可致婴儿数月不必要管理,需更大研究明确PCR在该人群的性能特征。

核心结论

  • 小样本病例系列支持对新生儿皮肤黏膜样本使用分子检测,但需更大研究更全面定义PCR性能特征。
  • 诊断决策应基于支持特定检测使用的数据,因假阳性可导致婴儿数月不必要且有潜在危害的管理。

研究设计与样本

  • 针对7例新生儿HSV病患者皮肤和黏膜样本,比较PCR检测HSV DNA与病毒培养的性能。

主要发现

  • 研究描述了7例新生儿HSV病患者皮肤黏膜样本中PCR检测HSV DNA与病毒培养的性能比较。
  • 许多诊断实验室已转向皮肤黏膜拭子分子诊断,很大程度上因病毒培养相关人力成本。

临床怎么用

  • 对新生儿皮肤黏膜样本可考虑使用分子检测替代病毒培养,但需认识小样本研究的局限性。
  • 诊断决策应基于支持特定检测使用的数据,权衡假阳性导致数月不必要管理的风险。

局限性

  • 为小样本病例系列(7例),需更大研究更全面定义PCR在该人群的性能特征。
  • 许多地区转向分子诊断主要基于经济理由而非充分科学证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In their article in this issue of the Journal of Clinical Microbiology, S. R. Dominguez et al. (J Clin Microbiol 56:e00632-18, 2018, https://doi.org/10.1128/JCM.00632-18) describe the performance of PCR detection of herpes simplex virus (HSV) DNA versus viral culture in skin and mucosal samples from 7 neonates with HSV disease. This is a significant contribution to our understanding of the optimal diagnostic approach in babies being evaluated for neonatal HSV disease. Many diagnostic laboratories already have made the change to molecular diagnostics for skin and mucosal swab testing, however, in large part due to the labor costs associated with viral cultures. Thus, important studies such as this one are being conducted to support a decision that has already been made in many locations on mostly economic grounds. This small case series supports the decision to use molecular testing for samples from skin and mucosal sites, but larger studies are needed to more fully define the performance characteristics of PCR in this population. Since a false-positive result would commit a baby to months of management that would be unnecessary and have potential harm, it is critical to base diagnostic decision making on data that support the use of a specific test.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Kimberlin DW. The Tail Wagging the Dog (or the Challenges Faced When the Financing of Medicine Gets Ahead of the Science of Medicine). J Clin Microbiol. 2018. PMID: 30021827. doi:10.1128/JCM.00904-18

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。